Patents by Inventor Paul A. Liberti
Paul A. Liberti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20030129676Abstract: A highly sensitive assay is disclosed which combines immunomagnetic enrichment with multiparameter flow cytometric and immunocytochemical analysis to detect, enumerate and characterize carcinoma cells in the blood. The assay can detect one epithelial cell or less in 1 ml of blood and has a greater sensitivity than conventional PCR or immunohistochemistry by 1-2 orders of magnitude. In addition, the assay facilitates the biological characterization and staging of carcinoma cells.Type: ApplicationFiled: October 11, 2002Publication date: July 10, 2003Inventors: Leon W.M.M. Terstappen, Galla Chandra Rao, Jonathan W. Uhr, Emilian V. Racila, Paul A. Liberti
-
Patent number: 6551843Abstract: Disclosed is a method that improves the efficiency of reactions between specific binding pairs. By translating one member of the pair through a suspension of the second member, or across a surface to which the second member is immobilized, collision and binding frequencies are greatly increased. The resulting increased binding frequency allows for reduced incubation times and lower incubation temperatures. The enhanced collisions are advantageous for both molecular reactions, in which mixing is not always effective, and cellular reactions, in which the cells may be damaged by mixing.Type: GrantFiled: January 29, 1999Date of Patent: April 22, 2003Assignee: Immunivest CorporationInventors: Galla Chandra Rao, Leon Terstappen, Paul Liberti
-
Publication number: 20020172987Abstract: Methods and compositions are provided for detecting circulating tumor cells and assessing said cells for alterations in tumor-diathesis associated molecules.Type: ApplicationFiled: February 19, 2002Publication date: November 21, 2002Inventors: Leon W.M.M. Terstappen, Galla Chandra Rao, Shawn Mark O'Hara, Paul A. Liberti, Steven Gross, Gerald Doyle
-
Publication number: 20020141913Abstract: Separation apparatus and method for separating magnetic and/or magnetically-labeled particles from a test medium.Type: ApplicationFiled: February 6, 2002Publication date: October 3, 2002Inventors: Leon W.M.M. Terstappen, Gerald V. Doyle, Paul A. Liberti, Gerald J. Dolan
-
Patent number: 6365362Abstract: A highly sensitive assay is disclosed which combines immunomagnetic enrichment with multiparameter flow cytometric and immunocytochemical analysis to detect, enumerate and characterize carcinoma cells in the blood. The assay can detect one epithelial cell or less in 1 ml of blood and has a greater sensitivity than conventional PCR or immunohistochemistry by 1-2 orders of magnitude. In addition, the assay facilitates the biological characterization and staging of carcinoma cells.Type: GrantFiled: February 12, 1999Date of Patent: April 2, 2002Assignees: Immunivest Corporation, Board of Regents, The University of Texas System.Inventors: Leon W. M. M. Terstappen, Galla Chandra Rao, Jonathan W. Uhr, Emilian V. Racila, Paul A. Liberti
-
Patent number: 6361749Abstract: Separation apparatus and method for separating magnetic and/or magnetically-labeled particles from a test medium in a reaction chamber which incorporates baffles, a spinner, a stirrer, or a plunger operable to be displaced along a collection surface to define a narrow flow path through which the particle-laden test medium must flow. The collection surface is a thin-walled non-magnetic material having a plurality of magnetic pole faces positioned therearound. Test medium within a reaction chamber is caused to flow past a collecting surface, and a high-gradient magnetic field is applied to the surface to capture magnetically responsive particles in the test medium. The particles are deflected toward the collection surface in the flow path for the test medium. The narrow flow path assures that substantially all of the particles pass within the high-gradient magnetic field along the collection surface.Type: GrantFiled: August 18, 1999Date of Patent: March 26, 2002Assignee: Immunivest CorporationInventors: Leon M. M. Terstappen, Gerald V. Doyle, Paul A. Liberti, Gerald J. Dolan
-
Publication number: 20020009759Abstract: A highly sensitive assay is disclosed which combines immunomagnetic enrichment with multiparameter flow cytometric and immunocytochemical analysis to detect, enumerate and characterize carcinoma cells in the blood. The assay can detect one epithelial cell or less in 1 ml of blood and has a greater sensitivity than conventional PCR or immunohistochemistry by 1-2 orders of magnitude. In addition, the assay facilitates the biological characterization and staging of carcinoma cells.Type: ApplicationFiled: July 13, 2001Publication date: January 24, 2002Inventors: Leon W.M.M. Terstappen, Galla Chandra Rao, Jonathan W. Uhr, Emilian V. Racila, Paul A. Liberti
-
Publication number: 20010018192Abstract: Stabilized control cells, methods for making the same and kits comprising the stabilized cells are disclosed. Also provided are improved methods for detecting rare cells in biological samples.Type: ApplicationFiled: March 7, 2001Publication date: August 30, 2001Inventors: Leon W.M.M. Terstappen, Galla Chandra Rao, Herman Rutner, Paul A. Liberti
-
Patent number: 6120856Abstract: The invention relates to an improved method for the manufacture of magnetically responsive particles, also called ferrofluids. The improved method involves a heat treatment step, which may occur at various times during the preparation of the materials, including during subdivision of the magnetic starting material, during the addion of a coating material, after formation of a magnetically responsive particle, or some combination thereof. The materials formed by such a process have numerous advantages over materials formed by other processes, including enhanced salt stability, increased coating uptake, and increased binding capacity. These ferrofluids have applications in a variety of preparative and diagnostic techniques, including immunoassay, cell separations, toxicity testing, food testing, environmental analysis, and MRI.Type: GrantFiled: October 14, 1997Date of Patent: September 19, 2000Assignee: Immunivest CorporationInventors: Paul A. Liberti, Galla C. Rao, Joseph N. Chiarappa
-
Patent number: 6013188Abstract: A method of qualitative analysis of microscopic biological specimens is disclosed in which the specimens are rendered magnetically responsive by immunosspecific binding with feuromagnetic colloid. The specimens are placed in a vessel having a feuromagnetic capture structure supported on a transparent wall. The vessel is then placed in a magnetic field for inducing a high gradient region in the vicinity of the capture structure and, in particular, adjacent to the capture structure along the direction of the applied field. The magnetically responsive specimens are collected and immobilized by the high gradient along the wall adjacent to the capture structure for unobstructed microscopic observation. Subpapulations of distinct types of cells can thus be observed and differentiated. As transport force, such as gravity or an externally applied magnetic gradient, may be applied to the vessel to move the specimens into the high gradient region.Type: GrantFiled: June 2, 1997Date of Patent: January 11, 2000Assignee: Immunivest CorporationInventors: Leon W. M. M. Terstappen, Paul A. Liberti
-
Patent number: 6013532Abstract: Microbiological entities, such as cells or microbes, are immobilized in a single-file linear array for optical analysis. Colloidal magnetic particles having a binding agent, such as ligand for attachment with a corresponding receptor, are bound to the entities suspended in a fluid medium. The fluid medium is placed into a vessel having a ferromagnetic capture structure including an elongated linear collection surface with a diameter less than that of the microbiological species of interest. The vessel is placed into a magnetic field for inducing a magnetic gradient in a region along the collection surface of the ferromagnetic capture structure. The magnetically-labeled entities are attracted toward the collection surface and immobilized thereon in a linear array. Microscopic optical and fluorescence observations, and sequential chemical reactions and mechanical manipulations may be performed on the line of immobilized entities.Type: GrantFiled: June 19, 1997Date of Patent: January 11, 2000Assignee: Immunivest CorporationInventors: Paul A. Liberti, Yuzhou Wang
-
Patent number: 5993665Abstract: A method of quantitative analysis of microscopic biological specimens in a fluid medium is disclosed in which the specimens are rendered magnetically responsive by immunospecific binding with ferromagnetic colloid. A known quantity of magnetically-responsive marker particles are added to the fluid medium. The fluid medium is then subjected to a magnetic separation process, to collect the magnetic species from the fluid. The collected species are resuspended in a second fluid medium, and the relative quantities thereof are enumerated to determine the concentration of the desired biological specimen in the first fluid medium. The marker particles may comprise magnetic particles having a relatively large magnetic moment, a magnetic moment approximately equal to the magnetically-labelled biological speciment of interest, or both in order to compensate the determination for variations in immunospecific binding affinity and/or magnetic collection efficiency.Type: GrantFiled: June 2, 1997Date of Patent: November 30, 1999Assignee: Immunivest CorporationInventors: Leon W. M. M. Terstappen, Paul A. Liberti
-
Patent number: 5876593Abstract: Biological entities such as cells, microbes, or components thereof are labeled with a magnetic colloid containing microscopic magnetic particles. The magnetic particles have a coating capable of biospecific or non-specific binding with the entities. An immobilization apparatus includes a non-magnetic vessel having a ferromagnetic collection structure for attracting the entities toward a collection surface upon which the magnetically labeled entities are immobilized subsequent to placement of the vessel on a support between two magnets. The ferromagnetic collection structure preferably has a sharp edge or high curvature for intensifying the magnetic field and for collecting the entities in a monolayer. The vessel includes an un-obstructed observation path so that immobilized entities may be observed and/or manipulated. The ferromagnetic collection structure may be arranged in various two dimensional patterns to provide a desired collection configuration.Type: GrantFiled: September 15, 1997Date of Patent: March 2, 1999Assignee: Immunivest CorporationInventors: Paul A. Liberti, Yuzhou Wang
-
Patent number: 5866099Abstract: A magnetic-polymer particle, useful in immunoassay techniques and various other biological/medical applications is produced by coprecipitation of transition metals in the presence of a polymer having available coordination sites. These particles are capable of forming stable aqueous suspensions and may be easily resuspended after agglomeration.Type: GrantFiled: April 30, 1997Date of Patent: February 2, 1999Assignee: Nycomed Imaging ASInventors: Charles S. Owen, John C. Silvia, Louis D'Angelo, Paul A. Liberti
-
Patent number: 5795470Abstract: A magnetic separation apparatus is disclosed herein. The apparatus includes a flow-through vessel defining a plenum and an inlet port for introducing fluid into the plenum. A hydrodynamic damping structure is provided between the inlet port and plenum for reducing turbulence in the fluid. A mounting device is provided with a slot therein for supporting and receiving the vessel. The mounting device also supports a first array of magnets along one side of the slot and arranged adjacent one another to face the slot with alternating polarity, and a second array of magnets along the opposite side of the slot from the first array arranged adjacent one another to face the slot with alternating polarity and confronting and magnetically opposing the magnets in the first array.Type: GrantFiled: June 7, 1995Date of Patent: August 18, 1998Assignee: Immunivest CorporationInventors: Yuzhou Wang, Weixin Tang, Paul A. Liberti
-
Patent number: 5741714Abstract: A method and apparatus for determining qualitatively or quantitatively the presence of analyte bound to a separation media without doing a bound/free separation. In the method, the bound fraction is collected in an assay region of a body of liquid which includes the free analyte, and the assay is performed by comparing the radiant-energy response in the assay region to the radiant-energy response in a control region of the body of liquid which is free of bound analyte. The apparatus has a chamber which contains the body of liquid, one or more collection elements and a control element and position in the body of liquid parallel to an opaque wall which has a colliminating slit in registry with each element. Each slit enables sensing of the radiant-energy response from the body of liquid between the slit and its associated elements.Type: GrantFiled: July 16, 1996Date of Patent: April 21, 1998Assignee: Immunivest CorporationInventor: Paul A. Liberti
-
Patent number: 5698271Abstract: The invention relates to an improved method for the manufacture of magnetically responsive particles, also called ferrofluids. The improved method involves a heat treatment step, which may occur at various times during the preparation of the materials, including during subdivision of the magnetic starting material, during the addion of a coating material, after formation of a magnetically responsive particle, or some combination thereof. The materials formed by such a process have numerous advantages over materials formed by other processes, including enhanced salt stability, increased coating uptake, and increased binding capacity. These ferrofluids have applications in a variety of preparative and diagnostic techniques, including immunoassay, cell separations, toxicity testing, food testing, environmental analysis, and MRI.Type: GrantFiled: June 7, 1995Date of Patent: December 16, 1997Assignee: Immunivest CorporationInventors: Paul A. Liberti, Galla C. Rao, Joseph N. Chiarappa
-
Patent number: 5660990Abstract: A method for determining the presence and/or concentration of a target substance e.g. protein, nucleic acid, bioparticle etc. in a fluid sample is provided. The method disclosed combines elements of immunoassays, coated cup assays and magnetic particle separation to effect the quantitation and recovery of an analyte in solution. Also the method ensures the non-reorientation of magnetically collected material by linking the magnetic particles to a collection surface via a specific binding pair. This linkage immobilizes the magnetic-analyte-containing material and thus allows for vigorous washing and reagent addition without significant redistribution or displacement. Thus the assay of this invention offers the speed of diffusion controlled kinetics as in a ferrofluid assay, the speed of collection of labeled target substance as in a magnetic assay as well as the ability to magnetically monolayer the ferrofluid, all of which is combined with the ease of washing and signal detection found in a coated cup assay.Type: GrantFiled: August 18, 1995Date of Patent: August 26, 1997Assignee: Immunivest CorporationInventors: Galla Chandra Rao, Paul A. Liberti
-
Patent number: 5646001Abstract: A method for separation of a mixture of biological entities into at least three distinct, subpopulations. Different antibodies are provided, with each antibody bound to a solid support in a unique manner such that by a manipulation of the physical or chemical environment, the bonds between the antibodies and the solid supports can be selectively broken. The mixed population of cells is incubated with the antibodies. The cells are magnetically separated from a test medium and collected in a monolayer upon a collection surface. Then by manipulation of the physicochemical environment, specific linkages can be broken and desired cell subpopulations released from the collection surface. This method has medically significant diagnostic and therapeutic applications, as entire cell types can be separated from non-malignant medically vital cell types. Cancer can be diagnosed, staged, and monitored. Genetic analysis from maternal blood, CVS, or amniocentesis samples is possible.Type: GrantFiled: February 28, 1995Date of Patent: July 8, 1997Assignee: Immunivest CorporationInventors: Leon W. M. M. Terstappen, Galla C. Rao, Dhanesh I. Gohel, Brian P. Feeley, Steven Gross, Ellen S. Church, Paul A. Liberti
-
Patent number: 5622831Abstract: Methods and devices are disclosed which are useful for collecting magnetic materials in either internally or externally generated magnetic gradient fields, followed by resuspension into solution with a simple manipulation of the magnetic device. The methods provide for removal of excess reagent, washing of magnetic material, and resuspension for analysis, among other uses. The methods are applicable to all types of biological material that are susceptible to magnetic labelling, including, for example, cells, viruses, proteins, hormones, and receptor-ligand complexes. Several devices are disclosed to take advantage of the method for cellular and immunoassay applications, including both internal and external devices. Both flow-through and static separators are disclosed.Type: GrantFiled: June 7, 1995Date of Patent: April 22, 1997Assignee: Immunivest CorporationInventors: Paul A. Liberti, Yozhou Wang